Cargando…

MYSM1-AR complex-mediated repression of Akt/c-Raf/GSK-3β signaling impedes castration-resistant prostate cancer growth

Epigenetic alterations that lead to dysregulated gene expression in the progression of castration-resistant prostate cancer (CRPC) remain elusive. Here, we investigated the role of histone deubiquitinase MYSM1 in the pathogenesis of prostate cancer (PCa). Tissues and public datasets of PCa were eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jinbo, Hu, Xiangnan, Gao, Yongheng, Tang, Qisheng, Zhao, Zhining, Xi, Wenjin, Yang, Fan, Zhang, Wei, Song, Yue, Song, Bin, Wang, Tao, Wang, He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914400/ https://www.ncbi.nlm.nih.gov/pubmed/31761786 http://dx.doi.org/10.18632/aging.102482

Ejemplares similares

VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling
por: Sun, Jinbo, et al.
Publicado: (2020)

MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling
por: Chen, Xu, et al.
Publicado: (2021)

Sec-O-Glucosylhamaudol Inhibits RANKL-Induced Osteoclastogenesis by Repressing 5-LO and AKT/GSK3β Signaling
por: Cao, Jinjin, et al.
Publicado: (2022)

MYSM1 Suppresses Cellular Senescence and the Aging Process to Prolong Lifespan
por: Tian, Mingfu, et al.
Publicado: (2020)

MYSM1 Is Essential for Maintaining Hematopoietic Stem Cell (HSC) Quiescence and Survival
por: Huo, Yi, et al.
Publicado: (2018)

Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review
por: Fiore, Amanda, et al.
Publicado: (2020)

NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis
por: Jeter, Collene R, et al.
Publicado: (2016)

Expression of MYSM1 is associated with tumor progression in colorectal cancer
por: Li, Yongmin, et al.
Publicado: (2017)

Spalt-Like Protein 4 (SALL4) Promotes Angiogenesis by Activating Vascular Endothelial Growth Factor A (VEGFA) Signaling
por: Sun, Jinbo, et al.
Publicado: (2020)

Correction: Expression of MYSM1 is associated with tumor progression in colorectal cancer
por: Li, Yongmin, et al.
Publicado: (2017)

Deubiquitinase MYSM1 Is Essential for Normal Bone Formation and Mesenchymal Stem Cell Differentiation
por: Li, Ping, et al.
Publicado: (2016)

Epigenetic Regulation of Antibody Responses by the Histone H2A Deubiquitinase MYSM1
por: Jiang, Xiao-Xia, et al.
Publicado: (2015)

Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance
por: Belle, J I, et al.
Publicado: (2016)

Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma
por: Lin, Yun Hsiao, et al.
Publicado: (2021)

PHLDA3 impedes somatic cell reprogramming by activating Akt-GSK3β pathway
por: Qiao, Mengran, et al.
Publicado: (2017)

Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development
por: Liang, Yue, et al.
Publicado: (2023)

Mysm1 is required for interferon regulatory factor expression in maintaining HSC quiescence and thymocyte development
por: Huang, X F, et al.
Publicado: (2016)

Interaction of Deubiquitinase 2A-DUB/MYSM1 with DNA Repair and Replication Factors
por: Kroeger, Carsten, et al.
Publicado: (2020)

Genetic and Pharmacological Inhibition of Astrocytic Mysm1 Alleviates Depressive‐Like Disorders by Promoting ATP Production
por: Zhang, Heyang, et al.
Publicado: (2022)

Emerging proteins involved in castration-resistant prostate cancer via the AR-dependent and AR-independent pathways (Review)
por: Feng, Kangle, et al.
Publicado: (2023)

MYSM1/miR-150/FLT3 inhibits B1a cell proliferation
por: Jiang, Xiao-Xia, et al.
Publicado: (2016)

MYSM1 induces apoptosis and sensitizes TNBC cells to cisplatin via RSK3–phospho-BAD pathway
por: Guan, Xiaolin, et al.
Publicado: (2022)

Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
por: Sugiura, Masahiro, et al.
Publicado: (2020)

Mysm1 epigenetically regulates the immunomodulatory function of adipose‐derived stem cells in part by targeting miR‐150
por: Wang, Yu‐Han, et al.
Publicado: (2019)

MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth
por: Wilms, Christina, et al.
Publicado: (2017)

Novel non-AR therapeutic targets in castrate resistant prostate cancer
por: Toren, Paul J., et al.
Publicado: (2013)

Crosstalk between KIF15 and AR in castrate-resistant prostate cancers
por: Yang, Hanny, et al.
Publicado: (2022)

Long non-coding RNA BANCR mediates esophageal squamous cell carcinoma progression by regulating the IGF1R/Raf/MEK/ERK pathway via miR-338-3p
por: Song, Wei, et al.
Publicado: (2020)

Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer()()
por: Qiao, Yuanyuan, et al.
Publicado: (2016)

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
por: Li, Qiuhui, et al.
Publicado: (2018)

Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth
por: Luo, Jun, et al.
Publicado: (2020)

Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2
por: Labaf, Maryam, et al.
Publicado: (2022)

KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer
por: Lu, Dingheng, et al.
Publicado: (2021)

Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis
por: Fritsche-Guenther, Raphaela, et al.
Publicado: (2016)

2A-DUB/Mysm1 Regulates Epidermal Development in Part by Suppressing p53-Mediated Programs
por: Wilms, Christina, et al.
Publicado: (2018)

The deubiquitinase MYSM1 dampens NOD2-mediated inflammation and tissue damage by inactivating the RIP2 complex
por: Panda, Swarupa, et al.
Publicado: (2018)

Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC)
por: Chandrasekaran, Balaji, et al.
Publicado: (2023)

Kaempferide Protects against Myocardial Ischemia/Reperfusion Injury through Activation of the PI3K/Akt/GSK-3β Pathway
por: Wang, Dong, et al.
Publicado: (2017)

Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression
por: Lai, Trang Huyen, et al.
Publicado: (2021)

Selective degradation of AR-V7 to overcome castration resistance of prostate cancer
por: Liu, Yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nck1mr0ni61j66tphtam99ohcc